Co-Chairs: Keith Barton, Consultant Ophthalmologist, Moorfields Eye Hospital, London, UK Kuldev Singh, Professor of Ophthalmology and Director of Glaucoma Service, Stanford, USA
Ophthalmic Market Overview And Outlook
Chair: Brian Scullion, Managing Director and Partner, William Blair and Company, USA
Ophthalmic Imaging Expertise And Cataract Surgical Innovation – Essential, Desirable Or Redundant?
Chair: Gerd Auffarth, Chairman, Dept of Ophthalmology, University of Heidelberg, Germany
Panellists: Paul Rosen, Consultant Ophthalmic Surgeon, Oxford Eye Hospital and Senior Lecturer, University of Oxford, UK Ralf Kuschnereit, Head of Ophthalmic Systems Division, Carl Zeiss Meditec AG, Germany Dave Scott, Division Vice President , Abbott Medical Optics Inc. Julian Stevens, Consultant Ophthalmic Surgeon, Moorfields Eye Hospital, London, UK
08:30 – 08:37 iOptics BV | Jeoren Cammeraat, Chief Executive Officer 08:37 – 08:44 Intelon Optics | Dominik Beck, Senior Advisor 08:44 – 08:51 Kali Care | Sina Fateh, Founder and Chief Executive Officer 08:51 – 08:58 TearLab | Seph Jenson, President and Chief Operating Officer 08:58 – 09:05 Intuor Technologies | Sean McCafferty, Chief Executive Officer 09:05 – 09:12 Second Sight | Robert Greenberg, President and Chief Executive Officer 09:12 – 09:19 Pixium-Vision | Khalid Ishaque, Chief Executive Officer 09:19 – 09:25 Summary
Anti VEGF Therapy: Will Injections Prevail Over Gene Therapy And Other Approaches?
Chair: José-Alain Sahel, Director of the Vision Institute, Inserm-UPMC, Professor of Ophthalmology Pierre & Marie Curie Medical School,Paris, France; Cumberlege Professor of Biomedical Sciences, University College London, UK
Panellists: Samir Patel, Co-Founder and President of Ophthotech Corporation, USA
Peter Richardson, Chief Medical Officer, Alcon, USA Reza Haque, Therapeutic Area Head for Ophthalmology, Shire Plc., USA
Ophthalmic Pharma Innovation: Will The Breakthroughs Come In House Or Via Acquisition?
Chair: Kuldev Singh, Professor of Ophthalmology and Director of Glaucoma Service, Stanford, USA
Panellists: José-Alain Sahel, Director of the Vision Institute, Inserm-UPMC, Professor of Ophthalmology Pierre & Marie Curie Medical School,Paris, France Cumberlege Professor of Biomedical Sciences, University College London, UK
Naveed Shams, President and Chief Executive Officer, Santen Inc., USA Eugene de Juan, Founder and Vice Chairman, ForSight Labs, USA and Jean Kelly Stock Distinguished Chair in Ophthalmology, UCSF, San Francisco, USA Baldo Scassellati Sforzolini, Senior Vice President Clinical Development, Allergan, USA Robert Dempsey, Vice President and Business Unit Head, Shire Ophthalmics, USA
10:50 – 10:57 Envisia | Ben Yerxa, President and Co-Founder 10:57 – 11:04 Jade Therapeutics | MaryJane Rafii, Chief Operations Officer and Co-Founder 11:04 – 11:11 ForSight Vision5 | Anne Rubin, Vice President of Marketing, ForSight Vision5 11:11 – 11:18 Ace Vision Group | Anne Marie, Hipsley Founder 11:18 – 11:25 Acufocus | Nick Tarantino, Chief Clinical and Regulatory Officer 11:25 – 11:32 MEDICEM | Eugen Chicevic, Co-Founder and Chief Executive Officer 11:32 – 11:35 Summary
Is IOL Technology Retarding The Adoption Of Femtosecond Cataract Surgery?
Chair: Boris Malyugin, Chief of Department of Cataract and Implant Surgery, Deputy Director General, S. Fyodorov Eye Microsurgery Comples State Institution, Moscow, Russia
Panellists: Sunil Shah, Consultant Ophthalmologist and Honorary Consultant at the Birmingham Children’s Hospital, Honorary Professor at The University of Ulster, UK
Beatrice Cochener, Professor, Chairman, Ophthalmology Department, University Hospital, Brest, France Calvin Roberts, Senior Vice President, Chief Medical Officer, Bausch + Lomb, USA Tom Dunlap, Supervisory Board Member, i-Optics BV. Executive Vice President, Sand Hill Consulting Associates, USA Stephen Lane, Clinical Professor of Ophthalmology, University of Minnesota, USA Laurent Attias, Senior Vice President, Head of Strategy, BD&L and Market Access, Alcon, USA
The Ophthalmologist Innovation Awards Launch
The Ophthalmologist’s Dilemma In Working With Startups: Is It Better To Take Stock Or Consulting Fees?
Panellists: Arthur Cummings, Consultant Eye Surgeon, Wellington Eye Clinic and Consultant Ophthalmologist and Chair of the Department of Ophthalmology, Beacon Hospital,
Dublin, Ireland Gerd Auffarth, Chairman, Dept of Ophthalmology, University of Heidelberg, Germany Stephen Lane, Clinical Professor of Ophthalmology, University of Minnesota, USA Jonathan Crowston, Ringland Anderson, Professor of Ophthalmology and Department Chair, University of Melbourne, Australia Richard A. Lewis, Grutzmacher Lewis Sierra Sacramento Eye Consultants, USA
13:40-13:47 Implandata Ophthalmic Products GmbH, Max G Ostermeier Co-Founder and General Manager 13:47 – 13:54 Sensimed AG | David Bailey, Chief Executive Officer and Board Member 13:54 – 14:01 iMvalv | Fabio Guarnieri, Chief Executive Officer 14:01 – 14:08 iOPtima Ltd | Ronen Castro, Chief Executive Officer 14:08 – 14:15 Innfocus Inc. | Russ Trenary, President and Chief Executive Officer 14:15 – 14:22 Aquesys Inc. | Ron Bache, President and Chief Executive Officer 14:22 – 14:29 Ivantis | Dave Van Meter, Chairman, President and Chief Executive Officer 14:29 – 14:36 Transcend Medical Inc. | Brian Walsh, President and Chief Executive Officer
14:36 – 14:45 Summary
Regulatory Standards For Premium IOLs
Chair: Malvina Eydelman Director, Division of Ophthalmic and Ear, Nose and Throat Devices ODE/CDRH/FDA, USA
Panellists: Scott Macrae, Professor of Ophthalmology, Professor of Visual Science, University of Rochester Medical Centre, Rochester, NY, USA
Jack Holladay, Clinical Professor of Ophthalmology Baylor College of Medicine, Houston, USA Samuel Masket, Clinical Professor of Ophthalmology at the Geffen School of Medicine, UCLA, USA
Does Minimally Invasive Glaucoma Surgery Address A True Unmet Need?
Chair: Norbert Pfeiffer, Medical Director, Mainz University Medical Centre, Mainz, Germany
Panellists: Tom Samuelson, Founding Partner and Attending Surgeon, Minnesota Eye Consultants, USA
Alan Crandall, MD John A. Moran Presidential Professor; Senior Vice Chair, Director of Glaucoma Cataract; Moran Eye Centre, University of Utah, Salt Lake City, USA Chris Calcaterra, Chief Commercial Officer, Glaukos, USA Brian Walsh, President and Chief Executive Officer Transcend Medical, USA Julian Garcia Feijoo, Professor and Chairman Ophthalmology Department. Universidad Complutense, Hospital Clinico San Carlos, Spain Paul Chew, Professor of Ophthalmology, National University of Singapore, Singapore Naveed Siddiqi, Partner, Edmond de Rothschild Investment Partners, London
Refractive Surgery: Laser Or Lens Exchange For Myopia And Astigmatism?
Chair: Marie Jose Tassignon Chief and Head of the Department of Ophthalmology Medical Director University Hospital, Belgium
Panellists: Abhay Vasavadava Founder and Director, Iladevi Cataract and IOL Research Centre, Raghudeep Eye Hospital, Ahmedabad, India
Michael Mrochen, Founder and Chief Executive Officer, IROC Science, Switzerland Sonia Yoo, Professor of Ophthalmology, Associate Medical Director at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, USA Soon Phaik Chee, Senior Consultant and Head for Cataract Subspecialty Service and Ocular Inflammation and Immunology Service, Singapore National Eye Centre, Singapore
The Pros and Cons of Leaving a Comfortable Big Company Job to Join a Start Up
Chair: Leonard Borrmann, Divisional Vice President Research and Development, Abbott Medical Optics Inc., USA
Panellists: Greg Kunst, Director, Global Market Access and New Business Planning, Glaukos Corporation, USA
Russ Trenary, President and Chief Executive Officer, InnFocus Inc., USA Robert Dempsey, Vice President & Business Unit Head, Shire Ophthalmics Nick Tarantino, Chief Clinical and Regulatory Officer, AcuFocus, Inc
BUYERS AND SELLERS: A View From The Top
Chair: James Mazzo, Chairman and Chief Executive Officer of Acufocus and Executive Chairman of Neurotech
Panellists: Jeffrey George, President and Global Head Alcon Inc., Novartis Group Executive Committee Member, USA
William J Link PhD, Managing Director Versant Ventures, USA Angela MacFarlane, President and Chief Executive Officer, ForSight VISION4, Inc. Managing Member, ForSight Labs, LLC, USA Ludwin Monz, President and CEO, Carl Zeiss Meditec AG, Germany Robert Ford, Executive Vice President, Medical Devices, Abbott Laboratories, USA Naveed Shams, President and Chief Executive Officer, Santen Inc., USA
SHARK TANK (see below)
Thank You and Goodbye
“It’s a wonderful meeting, we bring together investors, industry people, physicians and talk about innovations in ophthalmology” – Greg Kunst, Glaukos
“It’s a great platform for getting an overview of what’s going on in the industry” – Michael Mrochen